Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products
Introduction. Advanced therapy medicinal products (ATMPs) rely on recent advances in medical science, but alongside with potential benefits they may also bring safety concerns for patients. The inherent complexity of the ATMP production and use calls for special approaches to risk management through...
Saved in:
| Main Authors: | A. A. Taube, N. Yu. Velts |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-09-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell-based medicinal products: a review of current research
by: E. V. Galitsyna, et al.
Published: (2024-12-01) -
Advances and obstacles of T cell-based immunotherapy in gynecological malignancies
by: Xi Zhao, et al.
Published: (2025-07-01) -
T cells in cancer: mechanistic insights and therapeutic advances
by: Jingjing Pu, et al.
Published: (2025-07-01) -
Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01)